| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 43.02× | 43.02× | 45.97× | 48.59× | 54.43× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.75× | 3.48× | 2.98× | 2.95× | 2.39× | ||
| 1.28× | 1.28× | 1.39× | 1.34× | 1.24× | ||
| 1.75× | 1.75× | 1.42× | 1.42× | 1.46× | ||
| 0.89× | 0.89× | 0.91× | 0.79× | 0.81× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 54.43 | 48.59 | 45.97 | 43.02 | 43.02 | |
| Working Capital Turnover | 2.39 | 2.95 | 2.98 | 3.48 | 3.75 | |
| Asset Turnover | 1.24 | 1.34 | 1.39 | 1.28 | 1.28 | |
| Cash Conversion (CFO/Net Income) | 1.46 | 1.42 | 1.42 | 1.75 | 1.75 | |
| CFO/EBITDA | 0.81 | 0.79 | 0.91 | 0.89 | 0.89 |